檢索結果 - Judith Balmañà

Refine Results
  1. 1
    BRCA in breast cancer: ESMO Clinical Practice Guidelines

    BRCA in breast cancer: ESMO Clinical Practice Guidelines 由 Judith Balmañà, Orland Dı́ez, Isabel T. Rubio, M. Castiglione

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines

    Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines 由 Judith Balmañà, Francesc Balaguer, Andrés Cervantes, Dirk Arnold

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making?

    Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making? 由 Benedetta Pellegrino, Joaquı́n Mateo, Violeta Serra, Judith Balmañà

    出版 2019
    獲取全文 獲取全文
    Editorial
    加到收藏夾
    Saved in:
  4. 4
    BRCA in breast cancer: ESMO Clinical Practice Guidelines

    BRCA in breast cancer: ESMO Clinical Practice Guidelines 由 Judith Balmañà, Orland Dı́ez, Isabel T. Rubio, Fátima Cardoso

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

    Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† 由 Neda Stjepanovic, Leticia Moreira, Fátima Carneiro, Francesc Balaguer, Andrés Cervantes, Judith Balmañà, Erika Martinelli

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines

    Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines 由 Eduardo Vilar, Maurizio Scaltriti, Judith Balmañà, Cristina Saura, Marta Guzmán, Joaquı́n Arribas, José Baselga, Josep Tabernero

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening

    Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening 由 Shani Paluch‐Shimon, Fátima Cardoso, Cristiana Sessa, Judith Balmañà, Maria João Cardoso, Fiona J. Gilbert, Elżbieta Senkus

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy

    Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy 由 Charlie Gourley, Judith Balmañà, Jonathan A. Ledermann, Violeta Serra, Rebecca Dent, Sibylle Loibl, Éric Pujade-Lauraine, Simon J. Boulton

    出版 2019
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  9. 9
    Validation and Extension of the PREMM1,2 Model in a Population-Based Cohort of Colorectal Cancer Patients

    Validation and Extension of the PREMM1,2 Model in a Population-Based Cohort of Colorectal Cancer Patients 由 Francesc Balaguer, Judith Balmañà, Sergi Castellví–Bel, Ewout W. Steyerberg, Montserrat Andreu, Xavier Llor, Rodrigo Jover, Sapna Syngal, Antoni Castells

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy

    Development and Validation of a Colon Cancer Risk Assessment Tool for Patients Undergoing Colonoscopy 由 Fay Kastrinos, John I. Allen, David H. Stockwell, Elena M. Stoffel, E. Francis Cook, Muthoka L. Mutinga, Judith Balmañà, Sapna Syngal

    出版 2009
    獲取全文
    Carta
    加到收藏夾
    Saved in:
  11. 11
    SEOM clinical guidelines in Hereditary Breast and ovarian cancer

    SEOM clinical guidelines in Hereditary Breast and ovarian cancer 由 Gemma Llort, Isabel Chirivella, Rafael Morales, Rafael Serrano del Rosal, A.B. Sánchez, Àlex Teulé, Elena Lastra, Joan Brunet, Judith Balmañà, Begoña Graña

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    A decade of clinical development of PARP inhibitors in perspective

    A decade of clinical development of PARP inhibitors in perspective 由 Joaquı́n Mateo, Christopher J. Lord, Violeta Serra, Andrew Tutt, Judith Balmañà, Marta Castroviejo‐Bermejo, Cristina Cruz, Ana Oaknin, Stan B. Kaye, Johann S. de Bono

    出版 2019
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)

    Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) 由 Marc Tischkowitz, Judith Balmañà, William D. Foulkes, Paul A. James, Joanne Ngeow, Rita K. Schmutzler, Nicoleta Voian, Myra J. Wick, Douglas R. Stewart, Tuya Pal

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018

    Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Soc... 由 Deepak Vangala, Estelle Cauchin, Judith Balmañà, Lucjan Wyrwicz, Eric Van Cutsem, Ulrich Güller, Antoni Castells, Fátima Carneiro, Pascal Hammel, Michel Ducreux, Jean‐Luc Van Laethem, Tamara Matysiak‐Budnik, Wolff Schmiegel

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

    Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing 由 Judith Balmañà, Laura DiGiovanni, Pragna Gaddam, Michael F. Walsh, Joseph Vijai, Zsofia K. Stadler, Katherine L. Nathanson, Judy E. Garber, Fergus J. Couch, Kenneth Offit, Mark E. Robson, Susan M. Domchek

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma

    Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma 由 Ricardo Errazquin, Estela Carrasco, Sonia Del Marro, Anna Suñol, Jorge Peral, Jessica Ortiz, Juan Carlos Rubio, Carmen Segrelles, Marta Dueñas, Alicia Garrido-Aranda, Martina Álvarez, Cristina Beléndez, Judith Balmañà, Ramón García‐Escudero

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing.

    Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing. 由 Charlie F Rowlands, Sophie Allen, Judith Balmañà, Susan M. Domchek, D. Gareth Evans, Helen Hanson, Nicoline Hoogerbrugge, Philip James, K.L. Nathanson, Mark E. Robson, Marc Tischkowitz, William D. Foulkes, Clare Turnbull

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Comparison of the clinical prediction model PREMM<sub>1,2,6</sub>and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer

    Comparison of the clinical prediction model PREMM<sub>1,2,6</sub>and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer 由 Fay Kastrinos, Ewout W. Steyerberg, Judith Balmañà, Rowena Mercado, Steven Gallinger, Robert W. Haile, Graham Casey, John L. Hopper, Loı̈c Le Marchand, Noralane M. Lindor, Polly A. Newcomb, Stephen N. Thibodeau, Sapna Syngal

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance

    BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance 由 Yifan Wang, Andrea J. Bernhardy, Joseph Nacson, John J. Krais, Yinfei Tan, Émmanuelle Nicolas, Marc R. Radke, Elizabeth Handorf, Alba Llop‐Guevara, Judith Balmañà, Elizabeth M. Swisher, Violeta Serra, Suraj Peri, Neil Johnson

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

    Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort 由 Serena Masciari, Deborah Dillon, M Rath, Mark E. Robson, Jeffrey N. Weitzel, Judith Balmañà, Stephen B. Gruber, James M. Ford, David Euhus, Alexandra Lebensohn, Melinda L. Telli, Stephen Pochebit, Georgios Lypas, Judy E. Garber

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: